Our broad portfolio offers products that aid in the delivery of medication, protect healthcare workers and patients from cross-infection and injury, manage patient airway and temperature, as well as deliver specialised care in areas of invitro fertilisation, diagnostics and emergency patient transport.
2015 Headline revenue £836m
2015 Operating profit margin 19.8%
Medication delivery systems (eg ambulatory infusion and syringe pumps) that relieve pain and treat patients with acute and chronic conditions
Safety-enabled devices (eg catheters, needles) protect healthcare workers and patients from needlestick injuries and cross-infection
Products reduce hospital acquired infections, alleviate breathing difficulties and maintain body temperature
Specialised care in areas such as IVF, diagnostics and emergency patient transport
We have operations in over 30 countries with manufacturing located in the US, UK, Mexico, Italy, Germany, Czech Republic, and China. We sell to approximately 120 markets and, while the US continues to be our largest single market with over 50% of sales, we continue to build our presence in developing markets.
Approximately three-quarters of our end user customers are hospitals with the remainder comprising the alternate care market, such as homecare, clinics, and other surgery centres, as well as OEM relationships. We have a direct sales presence in over 20 countries and distribution arrangements in approximately 100 others.